James J. Harding, MD

Assistant Attending
Memorial Sloan Kettering Cancer Center, United States

Presentation(s):

• 35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome

  Friday, March 24, 2023
  3:46 PM – 3:58 PM

  Disclosure information not submitted.

• 52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.

  Saturday, March 25, 2023
  10:56 AM – 11:06 AM

  Disclosure information not submitted.